APO Research
Talk to an analyst

APO RESEARCH · REPORT

Weight-loss Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Weight-loss Drugs Industry Research Report 2026

19 December 2025133 pages

Choose your research edition.

Industry ResearchWeight-loss Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Weight-loss Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Weight-loss Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Weight-loss Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Weight-loss Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Weight-loss Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Weight-loss Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Weight-loss Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Weight-loss Drugs include Ajinomoto Co. Inc., Amway Corp., Currax, Glanbia PLC, GlaxoSmithKline PLC, Health and Nutrition Ltd., Herbalife Nutrition Ltd., Kellogg Company and Kraft Heinz Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Weight-loss Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Weight-loss Drugs Market by Company

Ajinomoto Co. Inc.

Amway Corp.

Currax

Glanbia PLC

GlaxoSmithKline PLC

Health and Nutrition Ltd.

Herbalife Nutrition Ltd.

Kellogg Company

Kraft Heinz Company

Novo Nordisk

PepsiCo

Roar Ambition

Swiss Research Labs Ltd.

Ultimate life ltd

Wolfson Berg Ltd

Nestle

Abbott

Weight-loss Drugs Segment by Type

Powder

Softgels

Pills

Liquid

Others

Weight-loss Drugs Segment by Application

Hospitals and Clinics

Pharmacy

Online Sales

Others

Weight-loss Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight-loss Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Weight-loss Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight-loss Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Weight-loss Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Weight-loss Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Weight-loss Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Weight-loss Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Weight-loss Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Weight-loss Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Weight-loss Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Weight-loss Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Weight-loss Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Weight-loss Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Weight-loss Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Weight-loss Drugs, Product Type & Application Table 14. Global Weight-loss Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Weight-loss Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Ajinomoto Co. Inc. Company Information Table 19. Ajinomoto Co. Inc. Business Overview Table 20. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio Table 22. Ajinomoto Co. Inc. Recent Developments Table 23. Amway Corp. Company Information Table 24. Amway Corp. Business Overview Table 25. Amway Corp. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Amway Corp. Weight-loss Drugs Product Portfolio Table 27. Amway Corp. Recent Developments Table 28. Currax Company Information Table 29. Currax Business Overview Table 30. Currax Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Currax Weight-loss Drugs Product Portfolio Table 32. Currax Recent Developments Table 33. Glanbia PLC Company Information Table 34. Glanbia PLC Business Overview Table 35. Glanbia PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Glanbia PLC Weight-loss Drugs Product Portfolio Table 37. Glanbia PLC Recent Developments Table 38. GlaxoSmithKline PLC Company Information Table 39. GlaxoSmithKline PLC Business Overview Table 40. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio Table 42. GlaxoSmithKline PLC Recent Developments Table 43. Health and Nutrition Ltd. Company Information Table 44. Health and Nutrition Ltd. Business Overview Table 45. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 47. Health and Nutrition Ltd. Recent Developments Table 48. Herbalife Nutrition Ltd. Company Information Table 49. Herbalife Nutrition Ltd. Business Overview Table 50. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 52. Herbalife Nutrition Ltd. Recent Developments Table 53. Kellogg Company Company Information Table 54. Kellogg Company Business Overview Table 55. Kellogg Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Kellogg Company Weight-loss Drugs Product Portfolio Table 57. Kellogg Company Recent Developments Table 58. Kraft Heinz Company Company Information Table 59. Kraft Heinz Company Business Overview Table 60. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Kraft Heinz Company Weight-loss Drugs Product Portfolio Table 62. Kraft Heinz Company Recent Developments Table 63. Novo Nordisk Company Information Table 64. Novo Nordisk Business Overview Table 65. Novo Nordisk Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Novo Nordisk Weight-loss Drugs Product Portfolio Table 67. Novo Nordisk Recent Developments Table 68. PepsiCo Company Information Table 69. PepsiCo Business Overview Table 70. PepsiCo Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. PepsiCo Weight-loss Drugs Product Portfolio Table 72. PepsiCo Recent Developments Table 73. Roar Ambition Company Information Table 74. Roar Ambition Business Overview Table 75. Roar Ambition Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Roar Ambition Weight-loss Drugs Product Portfolio Table 77. Roar Ambition Recent Developments Table 78. Swiss Research Labs Ltd. Company Information Table 79. Swiss Research Labs Ltd. Business Overview Table 80. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio Table 82. Swiss Research Labs Ltd. Recent Developments Table 83. Ultimate life ltd Company Information Table 84. Ultimate life ltd Business Overview Table 85. Ultimate life ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Ultimate life ltd Weight-loss Drugs Product Portfolio Table 87. Ultimate life ltd Recent Developments Table 88. Wolfson Berg Ltd Company Information Table 89. Wolfson Berg Ltd Business Overview Table 90. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Wolfson Berg Ltd Weight-loss Drugs Product Portfolio Table 92. Wolfson Berg Ltd Recent Developments Table 93. Nestle Company Information Table 94. Nestle Business Overview Table 95. Nestle Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Nestle Weight-loss Drugs Product Portfolio Table 97. Nestle Recent Developments Table 98. Abbott Company Information Table 99. Abbott Business Overview Table 100. Abbott Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Abbott Weight-loss Drugs Product Portfolio Table 102. Abbott Recent Developments Table 103. Global Weight-loss Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Weight-loss Drugs Sales by Region (2021-2026) & (K Units) Table 105. Global Weight-loss Drugs Sales Market Share by Region (2021-2026) Table 106. Global Weight-loss Drugs Sales by Region (2027-2032) & (K Units) Table 107. Global Weight-loss Drugs Sales Market Share by Region (2027-2032) Table 108. Global Weight-loss Drugs Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Weight-loss Drugs Revenue Market Share by Region (2021-2026) Table 110. Global Weight-loss Drugs Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Weight-loss Drugs Revenue Market Share by Region (2027-2032) Table 112. North America Weight-loss Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 114. North America Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 115. North America Weight-loss Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Weight-loss Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Weight-loss Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 119. Europe Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 120. Europe Weight-loss Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Weight-loss Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Weight-loss Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Weight-loss Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Weight-loss Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Weight-loss Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 129. South America Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 130. South America Weight-loss Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Weight-loss Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Weight-loss Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Weight-loss Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Weight-loss Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 138. Global Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 139. Global Weight-loss Drugs Sales Market Share by Type (2021-2026) Table 140. Global Weight-loss Drugs Sales Market Share by Type (2027-2032) Table 141. Global Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Weight-loss Drugs Revenue Market Share by Type (2021-2026) Table 144. Global Weight-loss Drugs Revenue Market Share by Type (2027-2032) Table 145. Global Weight-loss Drugs Price by Type (2021-2026) & (US$/Unit) Table 146. Global Weight-loss Drugs Price by Type (2027-2032) & (US$/Unit) Table 147. Global Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 148. Global Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 149. Global Weight-loss Drugs Sales Market Share by Application (2021-2026) Table 150. Global Weight-loss Drugs Sales Market Share by Application (2027-2032) Table 151. Global Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Weight-loss Drugs Revenue Market Share by Application (2021-2026) Table 154. Global Weight-loss Drugs Revenue Market Share by Application (2027-2032) Table 155. Global Weight-loss Drugs Price by Application (2021-2026) & (US$/Unit) Table 156. Global Weight-loss Drugs Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Weight-loss Drugs Distributors List Table 160. Weight-loss Drugs Customers List Table 161. Weight-loss Drugs Industry Trends Table 162. Weight-loss Drugs Industry Drivers Table 163. Weight-loss Drugs Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Weight-loss Drugs Product Image Figure 5. Global Weight-loss Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Weight-loss Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Weight-loss Drugs Sales (2021-2032) & (K Units) Figure 8. Global Weight-loss Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Powder Product Image Figure 10. Softgels Product Image Figure 11. Pills Product Image Figure 12. Liquid Product Image Figure 13. Others Product Image Figure 14. Hospitals and Clinics Product Image Figure 15. Pharmacy Product Image Figure 16. Online Sales Product Image Figure 17. Others Product Image Figure 18. Global Weight-loss Drugs Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Weight-loss Drugs, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Weight-loss Drugs Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Weight-loss Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Weight-loss Drugs Sales by Region in 2025 Figure 24. Global Weight-loss Drugs Revenue by Region in 2025 Figure 25. North America Weight-loss Drugs Market Size by Country in 2025 Figure 26. North America Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 27. North America Weight-loss Drugs Revenue Market Share by Country (2021-2032) Figure 28. United States Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Weight-loss Drugs Market Size by Country in 2025 Figure 31. Europe Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 32. Europe Weight-loss Drugs Revenue Market Share by Country (2021-2032) Figure 33. Germany Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Asia Pacific Weight-loss Drugs Market Size by Country in 2025 Figure 39. Asia Pacific Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 40. Asia Pacific Weight-loss Drugs Revenue Market Share by Country (2021-2032) Figure 41. China Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Japan Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. South Korea Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. India Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Australia Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. China Taiwan Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South America Weight-loss Drugs Market Size by Country in 2025 Figure 50. South America Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 51. South America Weight-loss Drugs Revenue Market Share by Country (2021-2032) Figure 52. Mexico Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Brazil Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Middle East and Africa Weight-loss Drugs Market Size by Country in 2025 Figure 56. Middle East and Africa Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 57. Middle East and Africa Weight-loss Drugs Revenue Market Share by Country (2021-2032) Figure 58. Turkey Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. UAE Weight-loss Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Global Weight-loss Drugs Sales Market Share by Type (2021-2032) Figure 62. Global Weight-loss Drugs Revenue Market Share by Type (2021-2032) Figure 63. Global Weight-loss Drugs Price (US$/Unit) by Type (2021-2032) Figure 64. Global Weight-loss Drugs Sales Market Share by Application (2021-2032) Figure 65. Global Weight-loss Drugs Revenue Market Share by Application (2021-2032) Figure 66. Global Weight-loss Drugs Price (US$/Unit) by Application (2021-2032) Figure 67. Weight-loss Drugs Value Chain Figure 68. Weight-loss Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Weight-loss Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Powder
  • Softgels
  • Pills
  • Liquid
  • Others
Applications
  • Hospitals and Clinics
  • Pharmacy
  • Online Sales
  • Others
Companies covered
  • Ajinomoto Co. Inc.
  • Amway Corp.
  • Currax
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Health and Nutrition Ltd.
  • Herbalife Nutrition Ltd.
  • Kellogg Company
  • Kraft Heinz Company
  • Novo Nordisk
  • PepsiCo
  • Roar Ambition
  • Swiss Research Labs Ltd.
  • Ultimate life ltd
  • Wolfson Berg Ltd
  • Nestle
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Weight-loss Drugs Market Size (2021-2032)
  4. 2.2.2 Global Weight-loss Drugs Sales (2021-2032)
  5. 2.2.3 Global Weight-loss Drugs Market Average Price (2021-2032)
  6. 2.3 Weight-loss Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Powder
  9. 2.3.3 Softgels
  10. 2.3.4 Pills
  11. 2.3.5 Liquid
  12. 2.3.6 Others
  13. 2.4 Weight-loss Drugs by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospitals and Clinics
  16. 2.4.3 Pharmacy
  17. 2.4.4 Online Sales
  18. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Weight-loss Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Weight-loss Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Weight-loss Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Weight-loss Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Weight-loss Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Weight-loss Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Weight-loss Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Weight-loss Drugs, Established Date
  9. 3.9 Global Weight-loss Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Ajinomoto Co. Inc.
  2. 4.1.1 Ajinomoto Co. Inc. Company Information
  3. 4.1.2 Ajinomoto Co. Inc. Business Overview
  4. 4.1.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio
  6. 4.1.5 Ajinomoto Co. Inc. Recent Developments
  7. 4.2 Amway Corp.
  8. 4.2.1 Amway Corp. Company Information
  9. 4.2.2 Amway Corp. Business Overview
  10. 4.2.3 Amway Corp. Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Amway Corp. Weight-loss Drugs Product Portfolio
  12. 4.2.5 Amway Corp. Recent Developments
  13. 4.3 Currax
  14. 4.3.1 Currax Company Information
  15. 4.3.2 Currax Business Overview
  16. 4.3.3 Currax Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Currax Weight-loss Drugs Product Portfolio
  18. 4.3.5 Currax Recent Developments
  19. 4.4 Glanbia PLC
  20. 4.4.1 Glanbia PLC Company Information
  21. 4.4.2 Glanbia PLC Business Overview
  22. 4.4.3 Glanbia PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Glanbia PLC Weight-loss Drugs Product Portfolio
  24. 4.4.5 Glanbia PLC Recent Developments
  25. 4.5 GlaxoSmithKline PLC
  26. 4.5.1 GlaxoSmithKline PLC Company Information
  27. 4.5.2 GlaxoSmithKline PLC Business Overview
  28. 4.5.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio
  30. 4.5.5 GlaxoSmithKline PLC Recent Developments
  31. 4.6 Health and Nutrition Ltd.
  32. 4.6.1 Health and Nutrition Ltd. Company Information
  33. 4.6.2 Health and Nutrition Ltd. Business Overview
  34. 4.6.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio
  36. 4.6.5 Health and Nutrition Ltd. Recent Developments
  37. 4.7 Herbalife Nutrition Ltd.
  38. 4.7.1 Herbalife Nutrition Ltd. Company Information
  39. 4.7.2 Herbalife Nutrition Ltd. Business Overview
  40. 4.7.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio
  42. 4.7.5 Herbalife Nutrition Ltd. Recent Developments
  43. 4.8 Kellogg Company
  44. 4.8.1 Kellogg Company Company Information
  45. 4.8.2 Kellogg Company Business Overview
  46. 4.8.3 Kellogg Company Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Kellogg Company Weight-loss Drugs Product Portfolio
  48. 4.8.5 Kellogg Company Recent Developments
  49. 4.9 Kraft Heinz Company
  50. 4.9.1 Kraft Heinz Company Company Information
  51. 4.9.2 Kraft Heinz Company Business Overview
  52. 4.9.3 Kraft Heinz Company Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Kraft Heinz Company Weight-loss Drugs Product Portfolio
  54. 4.9.5 Kraft Heinz Company Recent Developments
  55. 4.10 Novo Nordisk
  56. 4.10.1 Novo Nordisk Company Information
  57. 4.10.2 Novo Nordisk Business Overview
  58. 4.10.3 Novo Nordisk Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Novo Nordisk Weight-loss Drugs Product Portfolio
  60. 4.10.5 Novo Nordisk Recent Developments
  61. 4.11 PepsiCo
  62. 4.11.1 PepsiCo Company Information
  63. 4.11.2 PepsiCo Business Overview
  64. 4.11.3 PepsiCo Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 PepsiCo Weight-loss Drugs Product Portfolio
  66. 4.11.5 PepsiCo Recent Developments
  67. 4.12 Roar Ambition
  68. 4.12.1 Roar Ambition Company Information
  69. 4.12.2 Roar Ambition Business Overview
  70. 4.12.3 Roar Ambition Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Roar Ambition Weight-loss Drugs Product Portfolio
  72. 4.12.5 Roar Ambition Recent Developments
  73. 4.13 Swiss Research Labs Ltd.
  74. 4.13.1 Swiss Research Labs Ltd. Company Information
  75. 4.13.2 Swiss Research Labs Ltd. Business Overview
  76. 4.13.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio
  78. 4.13.5 Swiss Research Labs Ltd. Recent Developments
  79. 4.14 Ultimate life ltd
  80. 4.14.1 Ultimate life ltd Company Information
  81. 4.14.2 Ultimate life ltd Business Overview
  82. 4.14.3 Ultimate life ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Ultimate life ltd Weight-loss Drugs Product Portfolio
  84. 4.14.5 Ultimate life ltd Recent Developments
  85. 4.15 Wolfson Berg Ltd
  86. 4.15.1 Wolfson Berg Ltd Company Information
  87. 4.15.2 Wolfson Berg Ltd Business Overview
  88. 4.15.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Wolfson Berg Ltd Weight-loss Drugs Product Portfolio
  90. 4.15.5 Wolfson Berg Ltd Recent Developments
  91. 4.16 Nestle
  92. 4.16.1 Nestle Company Information
  93. 4.16.2 Nestle Business Overview
  94. 4.16.3 Nestle Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Nestle Weight-loss Drugs Product Portfolio
  96. 4.16.5 Nestle Recent Developments
  97. 4.17 Abbott
  98. 4.17.1 Abbott Company Information
  99. 4.17.2 Abbott Business Overview
  100. 4.17.3 Abbott Weight-loss Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Abbott Weight-loss Drugs Product Portfolio
  102. 4.17.5 Abbott Recent Developments
5 Global Weight-loss Drugs Market Scenario by Region
  1. 5.1 Global Weight-loss Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Weight-loss Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Weight-loss Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Weight-loss Drugs Sales by Region: 2027-2032
  5. 5.3 Global Weight-loss Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Weight-loss Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Weight-loss Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Weight-loss Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Weight-loss Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Weight-loss Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Weight-loss Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Weight-loss Drugs Market Facts & Figures by Country
  15. 5.5.1 Europe Weight-loss Drugs Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Weight-loss Drugs Sales by Country (2021-2032)
  17. 5.5.3 Europe Weight-loss Drugs Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Weight-loss Drugs Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Weight-loss Drugs Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Weight-loss Drugs Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Weight-loss Drugs Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Weight-loss Drugs Market Facts & Figures by Country
  35. 5.7.1 South America Weight-loss Drugs Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Weight-loss Drugs Sales by Country (2021-2032)
  37. 5.7.3 South America Weight-loss Drugs Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Weight-loss Drugs Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Weight-loss Drugs Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Weight-loss Drugs Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Weight-loss Drugs Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Weight-loss Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Weight-loss Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Weight-loss Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Weight-loss Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Weight-loss Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Weight-loss Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Weight-loss Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Weight-loss Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Weight-loss Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Weight-loss Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Weight-loss Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Weight-loss Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Weight-loss Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Weight-loss Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Weight-loss Drugs Value Chain Analysis
  2. 8.1.1 Weight-loss Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Weight-loss Drugs Production Mode & Process
  5. 8.2 Weight-loss Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Weight-loss Drugs Distributors
  8. 8.2.3 Weight-loss Drugs Customers
9 Global Weight-loss Drugs Analyzing Market Dynamics
  1. 9.1 Weight-loss Drugs Industry Trends
  2. 9.2 Weight-loss Drugs Industry Drivers
  3. 9.3 Weight-loss Drugs Industry Opportunities and Challenges
  4. 9.4 Weight-loss Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst